This Perspective reviews large-scale genomics and longitudinal phenomics efforts and the insights they can provide into wellness. The authors describe their vision for the transformation of the current health care from disease-oriented to data-driven, wellness-oriented and personalized population health.
The targeted integration of large DNA payloads into primary human T cells can be efficiently achieved non-virally by leveraging Cas9-based editing and the DNA-repair pathway homology-mediated end joining.
Brain transplant is not a reality for humans or for any living organism. But there are human research experiments in which transplanted brain cells are used to help treat several diseases that affect the brain. So far, there are very few results and measured outcomes of brain cell transplant, but the concept of transplanting brain tissue has shown some promise in preliminary studies.
If you are interested in having a brain cell transplant procedure, you can talk to your healthcare provider and look for a university or research center where brain cell transplant procedures are being done. These procedures tend to be part of research studies, so you will likely need to enroll in a research study if you want to have this type of treatment.
The brain is composed of many different regions and cells. Neurons in the brain have dedicated functions, and they do not typically heal when they are damaged. Parkinson’s disease, stroke, multiple sclerosis (MS), epilepsy, Alzheimer’s disease, and head trauma are among the conditions for which brain cell transplant has been used for humans in an experimental setting.
Scientists have discovered that bacteria can form memory-like mechanisms, informing strategies that lead to dangerous infections in humans. These strategies include antibiotic resistance and the formation…
A recent study published in JAMA Network Open investigates the level of usage of hemp-derived cannabinoids, including cannabinol (CBN), cannabigerol (CBG), Delta 8-THC, and cannabidiol (CBD). The reason hemp-derived cannabinoids were chosen for the study was due to passage of the 2018 Farm Bill, which removed hemp from the definition of marijuana previously outlined in the Controlled Substances Act (CSA). However, THC is still classified as a Schedule I drug, meaning it’s still illegal under federal law, and despite the “de-scheduling” of hemp, there is presently no data regarding the estimated usage of hemp-derived cannabinoids.
“While the de-scheduling of hemp products initially opened up the market for CBD products, it also applies to the 100-plus cannabinoids also found in the plant,” said Dr. Kevin Boehnke, who is a Research Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center at the University of Michigan, and a co-author on the study. “That means, as with CBD, all of them can follow that same path and be sold in gas stations, as ingredients in cosmetics, as well as in dispensaries—there will likely be substantial proliferation of some of these compounds.”
For the study, the researchers conducted a cross-sectional survey study of individuals aged 18 and up inquiring about past-year use of hemp-derived cannabinoids. Of the 6,666 participants who received the survey, only 1,169 completed it. Of those 1,169 participants, the researchers found that 71.7 percent had heard of CBD compared to 41.2 percent, 18.4 percent, and 16.8 percent for Delta 8-THC, CBG, and CBN, respectively. Additionally, 21.2 percent of the participants reported using CBD within the past year compared to 11.9 percent, 5.2 percent, and 4.4 percent for Delta 8-THC, CBG, and CBN, respectively, with 25.5 percent of participants reporting using some type of emerging cannabinoid within the last year, as well.
New research from Oregon Health & Science University could one day lead to therapies that prevent or treat diseases and infections tied to a protein that’s found in all human cells.
A study published today in the journal Molecular Cell describes how the protein ubiquitin is modified during bacterial infection.
The study details the steps taken to create a form of the protein known as lysine 6 polyubiquitin, where a long chain of ubiquitin molecules are linked through the amino acid lysine. This form of ubiquitin helps cells communicate by sending a molecular message—communication that remains poorly understood.
Google has released a new Pro model of its latest AI, Gemini, and company sources say it has outperformed GPT-3.5 (the free version of ChatGPT) in widespread testing. According to performance reports, Gemini Ultra exceeds current state-of-the-art results on 30 of the 32 widely-used academic benchmarks used in large language model (LLM) research and development. Google has been accused of lagging behind OpenAI’s ChatGPT, widely regarded as the most popular and powerful in the AI space. Google says Gemini was trained to be multimodal, meaning it can process different types of media such as text, pictures, video, and audio.
Insider also reports that, with a score of 90.0%, Gemini Ultra is the first model to outperform human experts on MMLU (massive multitask language understanding), which uses a combination of 57 subjects such as math, physics, history, law, medicine and ethics for testing both world knowledge and problem-solving abilities.
The Google-based AI comes in three sizes, or stages, for the Gemini platform: Ultra, which is the flagship model, Pro and Nano (designed for mobile devices). According to reports from TechCrunch, the company says it’s making Gemini Pro available to enterprise customers through its Vertex AI program, and for developers in AI Studio, on December 13. Reports indicate that the Pro version can also be accessed via Bard, the company’s chatbot interface.
The model can help evolve “better methods for growing cells for blood transfusions, novel cell therapies, and hematopoietic stem cell transplants.”
Remarkably, heX-Embryoid models developed structures akin to blood islands, the initial sites supporting the generation of blood cells in developing embryos. The study identified progenitors for red blood cells, platelets, and various white blood cell types—a pivotal advancement in the field, according to the team.
Researchers claim the model successfully replicated a process closely resembling the initial stages of blood production in humans. “This is exciting because there are extensive possibilities to apply this model to better understand how blood is formed and develop better methods for growing cells for blood transfusions, novel cell therapies, and hematopoietic stem cell transplants,” said Mo Ebrahimkhani, senior author and an associate professor at the Pittsburgh Liver Institute and the Department of Bioengineering at Pitt, in a statement.
Continue reading “Scientists craft embryo model mimicking early human blood development” »
Tiny made from human windpipe cells encouraged damaged neural tissue to repair itself in a lab experiment — potentially foreshadowing a future in which creations like this patrol our bodies, healing damage, delivering drugs, and more.
The background: In a study published in 2020, researchers at Tufts University and the University of Vermont (UVM) harvested and incubated skin cells from frog embryos until they were tiny balls.
Continue reading “Tiny biobots surprise their creators by healing wound” »
